Investor Ab Class A · OMXSTO:INVE_A

Investor Ab Class A — Q2 2023 Earnings Presentation

35 slides from Investor Ab Class A's earnings presentation, Jul 17, 2023

  1. Slide 1: Interim Report January-June 2023

    Interim Report January-June 2023 Johan Forssell, CEO 1 Helena Saxon, CFO

  2. Slide 2: Strong performance and record net asset value

    Strong performance and record net asset value Macro outlook remains uncertain Ensuring high flexibility is imperative 2

  3. Slide 3: Adjusted NAV and TSR vs SIXRX, Q2 and YTD 2023

    % Q2 2023 % YTD 2023 15 20 17 16 15 10 9 11 6 10 5 2 5 0 0 Adjusted NAV TSR SIXRX Adjusted NAV TSR SIXRX 3

  4. Slide 4: Listed Companies - Performance

    Listed Companies - Performance % Total Return AstraZeneca 30 ABB 15% Total return 9% (SIXRX 2%), mainly 21% • 25 driven by Atlas Copco and ABB 20 SEB 10% • Divestment of nearly 30 percent of 15 our holding in Accelleron, for total 10 SEK 546bn proceeds of approx. SEK 1bn Epiroc 5 8% Atlas Copco 0 24

  5. Slide 5: Patricia Industries – Performance

    Patricia Industries – Performance Sarnova 9% Advanced Laborie Instruments Total return, amounted to 11% (ex cash) 12% • 6% Permobil • Sales growth for the major subsidiaries amounted to 22% 9% Three of which 13% organically in constant currency Scandinavia SEK 173bn 4% Piab • Adjusted EBITA grew 34%

  6. Slide 6: Patricia Industries – EBITDA 12m rolling

    Patricia Industries – EBITDA 12m rolling Sales: SEK 60bn EBITDA: SEK 14bn SEK m 4 500 14 000 4 000 12 000 3 500 10 000 3 000 2 500 8 000 2 000 6 000 1 500 4 000 1 000 500 2 000 0 0 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19

  7. Slide 7: Operating Performance

    Operating Performance Value, Organic growth,% Margins, % Change vs. SEK bn Q2 2023 Q2 2023 Q2 2022 EBITDA 12.9 4.8 8.6 36 EBITA 11.1 5.2 EBITDA 16.2 2.8 16.1 17 EBITA 14.2 2.7 EBITDA 20.0 4.1 15.2 13 EBITA 16.3 4.0 EBITDA 28.4 1.2 77.5 6 EBITA 25.0 1.4 EBITDA 28.2 0.3 9.3 4 EBITA 24.5 0.0 EBITDA 32.

  8. Slide 8: Activities during the quarter

    Antiseptics Activities during the quarter 3% Gloves 13% Group • Organic sales growth amounted to 6 percent in constant currency, driven by Wound Care and ORS. Share of sales, last 12 months Operating • The EBITA margin increased, driven by sales growth and lower logistics Wound (June 30, 2023) Room

  9. Slide 9: Investments in EQT

    Investments in EQT Performance EQT AB Fund investments Net annual cash flow to Investor Total return 3% Total return -1% Reported value growth 8% SEK m 8 000 Net cash flow Outstanding commitment 6 000 Launched Nexus, SEK 0.5bn to Investor EQT’s first strategy for SEK 24.4bn 4 000 individual investor

  10. Slide 10: Driving value creation

    Driving value creation Strong performance during the second quarter • Record net asset value • Strong outperformance in Listed Companies • Double-digit organic growth and strong profit growth in Patricia Industries Continue to future-proof our companies to drive sustainable profit growth Well prepar

  11. Slide 11: Interim Report January-June 2023

    Interim Report January-June 2023 Helena Saxon, CFO 11

  12. Slide 12: Adjusted Net Asset Value

    Adjusted Net Asset Value 16% Average annual 773 growth, SEK bn, with dividend adjusted added back, net asset value 5 years June 30, 2023 900 (SIXRX 11%) 800 700 600 500 400 300 200 100 0 2017 2018 2019 2020 2021 2022 2023 -100 Listed companies Patricia Industries Investments in EQT Other assets & li

  13. Slide 13: Total Return by Business Area

    Total Return by Business Area 2023 Q2 % 12 11% 10 9% 9% 8 6 4 3% 2 0 Listed Companies Patricia Industries Investments in EQT Total 13

  14. Slide 14: Listed Companies

    Listed Companies SEK 546 market value bn 69% of total adjusted assets

  15. Slide 15: Listed Companies – Contribution to NAV

    Listed Companies – Contribution to NAV TSR XX% SIXRX XX% TSR 9% 2023 Q2 SIXRX 2% SEK m 25 000 20 000 15 000 10 000 5 000 0 -5 000 15

  16. Slide 16: Patricia Industries

    Patricia Industries SEK 173 bn adjusted market value 22% of total adjusted assets

  17. Slide 17: Patricia Industries – Drivers of Estimated Market Values

    Patricia Industries – Drivers of Estimated Market Values SEK bn Total Return 11% (10% incl. cash) 185 Main drivers Earnings growth Currency impact Multiple expansion Cash flow 168 March 31, 2023 June 30, 2023 17

  18. Slide 18: Patricia Industries – Change in Estimated Market Values

    Patricia Industries – Change in Estimated Market Values SEK m Estimated market value change Distributions/proceeds 1 636 218 171 14 8 185 005 1 782 (30) (106) (487) 2 228 2 502 8 838 168 231 Q1 2023 Mölnlycke Sarnova BraunAbility Permobil Laborie Advanced Three Vectura Piab Atlas Financial Patricia

  19. Slide 19: Patricia Industries – Change in Estimated Market Values

    Patricia Industries – Change in Estimated Market Values SEK m Estimated market value change Distributions/proceeds 1 636 218 171 14 8 185 005 1 782 (30) (106) (487) 2 228 2 502 8 838 168 231 Q1 2023 Mölnlycke Sarnova BraunAbility Permobil Laborie Advanced Three Vectura Piab Atlas Financial Patricia

  20. Slide 20: Patricia Industries – Change in Estimated Market Values

    Patricia Industries – Change in Estimated Market Values SEK m Estimated market value change Distributions/proceeds 1 636 218 171 14 8 185 005 1 782 (30) (106) (487) 2 228 2 502 8 838 168 231 Q1 2023 Mölnlycke Sarnova BraunAbility Permobil Laborie Advanced Three Vectura Piab Atlas Financial Patricia

  21. Slide 21: Financial position

    Financial position

  22. Slide 22: Leverage in the Lower End of the Range, June 30, 2023

    Leverage in the Lower End of the Range, June 30, 2023 AA-/Aa3 Ratings S&P/ Moody’s % 20 15 10 5 0 2019 2020 2021 2022 2023 -5 Leverage target range Leverage 22

  23. Slide 23: Average Annual Total Return, June 30, 2023

    Average Annual Total Return, June 30, 2023 % 35 30 25 20 15 10 5 0 YTD 1 year 5 years 10 years 20 years Investor B SIXRX Return requirement 23 23

  24. Slide 24: Financial Calendar

    Financial Calendar Viveka Hirdman-Ryrberg 2023-10-19 Head of Corporate Communication & Interim Management Statement Sustainability January-September 2023 +46 70 550 3500 2024-01-19 Viveka.hirdman-ryrberg@investorab.com Year-End Report 2023 2024-04-18 Interim Management Statement January-March 2024 2

  25. Slide 25: Appendix

    Appendix 25

  26. Slide 26: Activities during the quarter

    Antiseptics Activities during the quarter 3% Gloves 13% Group • Organic sales growth amounted to 6 percent in constant currency, driven by Share of sales, Wound Care and ORS. Wound last 12 months Operating • The EBITA margin increased, driven by sales growth and lower logistics (June 30, 2023) Room

  27. Slide 27: Activities during the quarter

    Activities during the quarter Negative impact from transaction and integration costs related to Clinical Negative impact from Innovations transaction costs related to • Organic sales growth amounted to 2 percent in constant currency. Growth Pelvalon and OptilumeTM was driven by the GI (Gastrointesti

  28. Slide 28: Activities during the quarter

    Negative impact Negative impact from transaction costs transaction from costs related related Negative impact from transaction costs related to Allied 100 acquisition, Activities during the quarter to Digitech to Digitech acquisition acquisition earn-out payment and integration costs related to Digi

  29. Slide 29: Activities during the quarter

    Activities during the quarter • Organic sales growth amounted to 13 percent in constant currency, supported by all regions. Aftermarket services, which is a prioritized area for Permobil, continued to report high growth. SEK m % 1 800 30 • The EBITA margin increased driven by operating leverage and

  30. Slide 30: Activities during the quarter

    Negative impact Activities during the quarter Negative impact from costs related to from costs related to Artel acquisition • Organic sales growth declined by 1 percent in constant currency and Solentim acquisition continued to be impacted by soft demand and a strong prior year comparison for instru

  31. Slide 31: Activities during the quarter

    Activities during the quarter Negative impact from costs related to Negative Negative impact impact • Organic sales growth amounted to 4 percent in constant currency, driven by from from write-down write-down and and TAWI acquisition transaction transaction costs costs Vacuum Automation and Vacuum C

  32. Slide 32: Activities during the quarter

    Activities during the quarter • Organic sales growth amounted to 36 percent in constant currency, led by strong demand across the product portfolio. SEK m % • The acquisitions of Q’Straint and the ProMaster wheelchair-accessible 350 14 vehicle conversion business are performing well. 300 12 • The EB

  33. Slide 33: Activities during the quarter

    Activities during the quarter • Total sales growth amounted to 9 percent, mainly driven by rent increases Grand Hôtel property divested, last quarter with due to annual indexation. revenues from Grand Hôtel SEK m % • The EBITDA margin decreased mainly driven by one-time costs. 100 80 • Vectura signe

  34. Slide 34: Activities during the quarter

    Activities during the quarter • Organic sales declined 6 percent in constant currency due to soft market demand. SEK m % • The EBITA margin decreased, mainly driven by one-time costs. 120 60 • Atlas Antibodies released a set of new monoclonal antibodies, 100 50 complementing the portfolio for cancer

  35. Slide 35: Activities during the quarter

    Activities during the quarter • The subscription base increased by 59,000, of which 38,000 in Sweden and 21,000 in Denmark. Three Sweden reached a milestone with 2.5 million subscriptions. SEK m % 3 500 70 • Service revenue increased by 11 percent, driven by a larger customer base 3 000 60 as well a

Investor — Q2 2023 Earnings Presentation on 6ix